Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Virtual Education

Welcome to the iCMLf Virtual Education Program

This Virtual Education Program, provided by the iCMLf offers a series of webcast presentations from leading hematologists.

These presentations provide updated information on treatment advances and best practice management of CML, including disease monitoring and new therapies. The sessions specifically address issues of CML care in countries with limited access to monitoring and supplemental treatments.

Modules des langues français

Módulos en español

 

COLT Meeting 2019: CML therapy - state of science

-- Virtual Education Program: 2019 Edition

 

Presentations from the COLT Meeting 2019

We are pleased to make available a series of presentations from the COLT Meeting 2019, a CML Opinion Leader Training that took place in Adelaide (Australia). Topics cover; CML therapy - state of science, management of CML, practicalities and monitoring TFR and Ph+ALL.

Timothy Hughes

 David Yeung 3 Devendra Hiwase

Session 1: CML therapy - state of science
Chair: Prof. Tim Hughes

  • Frontline Therapy for CML 
    (Prof Tim Hughes)
  • When frontline therapy fails
    (Dr David Yeung)
  • CML - Beyond chronic phase
    (Dr Devendra Hiwase)

 

COLT Meeting 2019: CML Management, Practicalities

 

Naranie

 David Yeung 3 Susan Branford                    

Session 2: CML Management, Practicalities
Chair: Dr David Yeung

  • Managing TKI toxicities
    (Dr Naranie Shanmuganathan)
  • Allograft - still a role in CML?
    (Dr David Yeung)
  • Molecular monitoring
    (A/Prof Susan Branford)

 

COLT Meeting 2019: Monitoring TFR and Ph+ ALL

 

Susan Branford

 

 David Yeung 3                  

 

Session 3: Monitoring TFR and Ph+ ALL
Chair: Dr Naranie Shanmunagathan

  • Monitoring TFR - Challenges 
    (A/Prof Susan Branford)
  • Ph+ ALL
    (Dr David Yeung)

 

COLT Meeting 2019: CML related topics

 

David Ross Devendra Hiwase Michael Osborn                    

Session 4: CML related topics
Chair: Dr David Ross

  • Myelofibrosis Management
    (Dr David Ross)
  • MPN/MDS Overlap Syndrome
    (Dr David Ross)
  • Pediatric CML
    (Dr Michael Osborn)

 

COLT Meeting 2019: The CML frontier

 

IMG 9703 John Reynolds

 David Ross Timothy Hughes                    

Session 5: The CML frontier
Chair: Prof Timothy Hughes

  • Biostats primer for CML clinicians
    (A/Prof John Reynolds)
  • TFR trial update
    (Dr David Ross)
  • Making TFR mainstream
    (Prof Timothy Hughes)